ASSESSING THE PRECISION OF CONTRAST-ENHANCED CT SCANS IN DIAGNOSING BRONCHOGENIC CARCINOMA USING HISTOPATHOLOGY AS THE REFERENCE CRITERION

Main Article Content

Hadia Faisal
Raisa Shahzadi
Aqsa Ayesha Masood
Ahmad Mehmood
Hassan Sadiq
Haroon Amin

Keywords

Contrast-enhanced computed tomography, bronchogenic carcinoma, CT Scan

Abstract

Background: Bronchogenic carcinoma is still a complicated, multifaceted illness with a variety of presentations determined by histological subtypes, diagnostic methods, and demographic factors. By using histopathology as the reference standard, the objective of this investigation is to thoroughly assess the efficacy of contrast-enhanced CT (CECT) scans in the identification of bronchogenic cancer.


Method: A group of patients between the ages of 20 and 80 who had been diagnosed with or were suspected of having bronchogenic carcinoma undertook a thorough analysis that looked at factors like gender distribution, age-related trends, connections with cigarette smoking, and propensities for metastasis across different histological subtypes. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were assessed for diagnostic instruments, CECT, and histology.


Results: The study showed a notable gender disparity, with most patients (65%) being men. The need of individualized approaches is highlighted by the fact that age-related trends varied across histological subtypes. Significant insights were gained from associations between smoking status and different subtypes of lung cancer, which confirmed the association between smoking and some subtypes while challenging preconceived assumptions in others. The need for individualized treatment plans was highlighted by the fact that metastatic tendencies varied among subtypes. With a PPV of 91% and an NPV of 67% for CECT and a PPV of 94% and an NPV of 73% for histopathology, respectively, both tests showed good sensitivity and specificity.


Conclusion: This study provides insights into the roles played by demographic parameters, histological subtypes, and diagnostic techniques in the complex terrain of bronchogenic carcinoma diagnosis. The results highlight how CECT and histology work in tandem to improve the diagnostic process' precision and dependability. Future study will be guided by restrictions, such as sample size and retrospective analysis, to improve diagnostic approaches and examine rapidly developing technology in the industry.

Abstract 56 | pdf Downloads 15

References

1. Chen, S., Li, X., Chen, M., Yin, Y., Li, N., & Li, Y. (2016). Limited diagnostic value of Dual-Time-Point 18F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses. European Journal of Radiology, 85(10), 1744–1749.
2. Dabrowska, M., Krenke, R., Korczynski, P., Maskey-Warzechowska, M., Zukowska, M., Kunikowska, J., Orłowski, T., & Chazan, R. (2015). Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules. Medicine (United States), 94(15), 1–7.
3. Davidson, M. R., Gazdar, A. F., & Clarke, B. E. (2013). The pivotal role of pathology in the management of lung cancer. Journal of Thoracic Disease, 5(SUPPL.5).
4. Erasmus, J. J., Connolly, J. E., McAdams, H. P., & Roggli, V. L. (2000). Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. In Radiographics (Vol. 20, Issue 1, pp. 43–58).
5. Faridi, N., & Ahmed, R. (1995). Patho-epidemiology of lung cancer in Karachi.
6. Gao, F., Li, M., Sun, Y., Xiao, L., & Hua, Y. (2017). Diagnostic value of contrast-enhanced CT scans in identifying lung adenocarcinomas manifesting as GGNs (ground glass nodules). Medicine (United States), 96(43), 1–6.
7. Gharraf, H. S., Mehana, S. M., & ElNagar, M. A. (2020). Role of CT in differentiation between subtypes of lung cancer; is it possible? The Egyptian Journal of Bronchology, 14(1).
8. Glazer, H. S., Kaiser, L. R., Anderson, D. J., Molina, P. L., Emami, B., Roper, C. L., & Sagel, S. S. (1989). Indeterminate Mediastinal Invasion in Bronchogenic Carcinoma: CT Evaluation’.
9. Haura, E. B. (2001). Treatment of advanced non-small-cell lung cancer: A review of current randomized clinical trials and an examination of emerging therapies. Cancer Control, 8(4), 326–336.
10. Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G.,
11. Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J., Altorki, N. K., & Smith, J. P. (1999). Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet (London, England), 354(9173), 99–105.
12. Herman, S. J., Winton, T. L., Weisbrod, G. L., Towers, M. J., & Mentzer, S. J. (1994). S From the Departments of Radiology. In Radiology (Vol. 190).
13. Hollings, N., & Shaw, P. (2002). Diagnostic imaging of lung cancer. European Respiratory Journal, 19(4), 722–742.
14. Izbicki, J. R., Thetter, O., Karg, O., Kreusser, T., Passlick, B., Trupka, A., Haussinger, K., Woeckel, W., Kenn, R. W., Wilker, D. K., Limmer, J., & Schweiberer, L. (1992). Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma: A prospective study. Journal of Thoracic and Cardiovascular Surgery, 104(2), 413–420.
15. Javed, F., Rehman, I., & Hasnain, S. (2020). ORIGINAL ARTICLE ACCURACY OF COMPUTED TOMOGRAPHY IN CHARACTERI- ZATION OF PULMONARY LESIONS. 30(December), 246–251.
16. Javed, F., ur Rehman, I., & Hasnain, S. (n.d.). ACCURACY OF COMPUTED TOMOGRAPHY IN CHARACTERI-ZATION OF PULMONARY LESIONS. 30(4), 246–251.
17. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69–90.
18. Khaliq, N., Jesrani, A., Mansoor, M. A., Nizamani, W. M., Mahmud, R., & Zaidi, M. H. (2017). Diagnostic Accuracy of Contrast Enhanced Computed Tomography in Detecting Bronchogenic Carcinoma-Experience At Liaquat National Hospital (Vol. 11, Issue 1).
19. Li, F., Sone, S., Abe, H., Macmahon, H., & Doi, K. (2004). Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology, 233(3), 793–798.
20. Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., Kwiatkowski, D. J., Ladanyi, M., Nowak, J. A., Sholl, L., Temple-Smolkin, R., Solomon, B., Souter, L. H.,
21. Thunnissen, E., Tsao, M. S., … Yatabe, Y. (2018). Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Journal of Molecular Diagnostics, 20(2), 129–159.
22. Luo, S., Li, X., Chen, S., Wang, D., & Tan, Y. (2016). Contrast-Enhanced Chest Computed Tomography (CT) Scan with Low Radiation and Total Iodine Dose for Lung Cancer Detection Using Adaptive Statistical Iterative Reconstruction. Iranian Journal of Radiology, 13(4).
23. MacMahon, H., Austin, J. H. M., Gamsu, G., Herold, C. J., Jett, J. R., Naidich, D. P., Patz,
24. E. F., & Swensen, S. J. (2005). Guidelines for management of small pulmonary nodules detected on CT scans: A statement from the Fleischner Society. In Radiology (Vol. 237, Issue 2, pp. 395–400).
25. MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta,
A. C., Ohno, Y., Powell, C. A., Prokop, M., Rubin, G. D., Schaefer-Prokop, C. M., Travis, W. D., Van Schil, P. E., & Bankier, A. A. (2017). Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. In Radiology (Vol. 284, Issue 1, pp. 228–243). Radiological Society of North America Inc.
26. McWilliams, A. M., Mayo, J. R., Ahn, M. I., MacDonald, S. L. S., & Lam, S. C. (2006). Lung Cancer Screening Using Multi-Slice Thin-Section Computed Tomography and Autofluorescence Bronchoscopy. Journal of Thoracic Oncology, 1(1), 61–68.
27. McWilliams, A., & Mayo, J. (2008). Computed tomography-detected noncalcified pulmonary nodules: A review of evidence for significance and management. In Proceedings of the American Thoracic Society (Vol. 5, Issue 9, pp. 900–904).
28. Nomori, H., Watanabe, K., Ohtsuka, T., Naruke, T., Suemasu, K., & Uno, K. (2004). Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer, 45(1), 19–27.
29. Pastorino, U., Bellomi, M., Landoni, C., De Fiori, E., Arnaldi, P., Picchio, M., Pelosi, G., Boyle, P., & Fazio, F. (2003). Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet (London, England), 362(9384), 593–597.
30. Purandare, N. C., & Rangarajan, V. (2015). Imaging of lung cancer: Implications on staging and management. Indian Journal of Radiology and Imaging, 25(2), 109–120.
31. Rami-Porta, R., Bolejack, V., Crowley, J., Ball, D., Kim, J., Lyons, G., Rice, T., Suzuki, K., Thomas, C. F., Travis, W. D., & Wu, Y. L. (2015). The IASLC lung cancer staging project: Proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. Journal of Thoracic Oncology, 10(7), 990–1003.
32. Schaefer-Prokop, C., & Prokop, M. (2002). New imaging techniques in the treatment guidelines for lung cancer. European Respiratory Journal, Supplement, 19(35), 71– 83.
33. Shetty, C. M., Lakhkar, B. N., Gangadhar, V. S. S., & Ramachandran, N. R. (2005). Changing pattern of bronchogenic carcinoma: A statistical variation or a reality? Indian Journal of Radiology and Imaging, 15(2), 233–238.
34. Sun, Y., Zhao, W., Kuang, K., Jin, L., Gao, P., Duan, S., Xiao, Y., Liu, J., & Li, M. (2022). Non-contrast and contrast enhanced computed tomography radiomics in preoperative discrimination of lung invasive and non-invasive adenocarcinoma. Frontiers in Medicine, 9(November), 1–10.
35. Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Sloan, J. A., Sykes, A. M., Aughenbaugh, G. L., & Clemens, M. A. (2003). Lung cancer screening with CT: Mayo clinic experience. Radiology, 226(3), 756–761.
36. Ur-Rehman, , Memon, W., Husen, Y., Akhtar, W., Sophie, R., & Baig, M. A. (2011). Accuracy of computed tomography in diagnosing malignancy in solitary pulmonary lesions. In Journal of the Pakistan Medical Association (Vol. 61, Issue 1).
37. Verschakelen, J. A., Bogaert, J., & De Wever, W. (2002). Computed tomography in staging for lung cancer. European Respiratory Journal, Supplement, 19(35), 40–48.